Global Dry Age-Related Macular Degeneration Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.
LPI (LP Information)' newest research report, the “Dry Age-Related Macular Degeneration Industry Forecast” looks at past sales and reviews total world Dry Age-Related Macular Degeneration sales in 2022, providing a comprehensive analysis by region and market sector of projected Dry Age-Related Macular Degeneration sales for 2023 through 2029. With Dry Age-Related Macular Degeneration sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Age-Related Macular Degeneration industry.
This Insight Report provides a comprehensive analysis of the global Dry Age-Related Macular Degeneration landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Age-Related Macular Degeneration portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dry Age-Related Macular Degeneration market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Age-Related Macular Degeneration and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Age-Related Macular Degeneration.
The global Dry Age-Related Macular Degeneration market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Dry Age-Related Macular Degeneration is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Dry Age-Related Macular Degeneration is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Dry Age-Related Macular Degeneration is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Dry Age-Related Macular Degeneration players cover Santen Pharmaceuticals, Allergan, Bausch Health, Alimera Science, Phio Pharmaceuticals, Ocumension Therapeutics, Belite Bio, Kubota Vision and Iveric Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Age-Related Macular Degeneration market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.
LPI (LP Information)' newest research report, the “Dry Age-Related Macular Degeneration Industry Forecast” looks at past sales and reviews total world Dry Age-Related Macular Degeneration sales in 2022, providing a comprehensive analysis by region and market sector of projected Dry Age-Related Macular Degeneration sales for 2023 through 2029. With Dry Age-Related Macular Degeneration sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dry Age-Related Macular Degeneration industry.
This Insight Report provides a comprehensive analysis of the global Dry Age-Related Macular Degeneration landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dry Age-Related Macular Degeneration portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dry Age-Related Macular Degeneration market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dry Age-Related Macular Degeneration and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dry Age-Related Macular Degeneration.
The global Dry Age-Related Macular Degeneration market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Dry Age-Related Macular Degeneration is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Dry Age-Related Macular Degeneration is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Dry Age-Related Macular Degeneration is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Dry Age-Related Macular Degeneration players cover Santen Pharmaceuticals, Allergan, Bausch Health, Alimera Science, Phio Pharmaceuticals, Ocumension Therapeutics, Belite Bio, Kubota Vision and Iveric Bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Age-Related Macular Degeneration market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral
- Injectables
- Above 40 Years
- Above 60 Years
- Above 75 Years
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Santen Pharmaceuticals
- Allergan
- Bausch Health
- Alimera Science
- Phio Pharmaceuticals
- Ocumension Therapeutics
- Belite Bio
- Kubota Vision
- Iveric Bio
- Eyestem Research
- Y2 Solution
- Stealth Biotherapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dry Age-Related Macular Degeneration Market Size 2018-2029
2.1.2 Dry Age-Related Macular Degeneration Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Dry Age-Related Macular Degeneration Segment by Type
2.2.1 Oral
2.2.2 Injectables
2.3 Dry Age-Related Macular Degeneration Market Size by Type
2.3.1 Dry Age-Related Macular Degeneration Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
2.4 Dry Age-Related Macular Degeneration Segment by Application
2.4.1 Above 40 Years
2.4.2 Above 60 Years
2.4.3 Above 75 Years
2.5 Dry Age-Related Macular Degeneration Market Size by Application
2.5.1 Dry Age-Related Macular Degeneration Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
3 DRY AGE-RELATED MACULAR DEGENERATION MARKET SIZE BY PLAYER
3.1 Dry Age-Related Macular Degeneration Market Size Market Share by Players
3.1.1 Global Dry Age-Related Macular Degeneration Revenue by Players (2018-2023)
3.1.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Players (2018-2023)
3.2 Global Dry Age-Related Macular Degeneration Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRY AGE-RELATED MACULAR DEGENERATION BY REGIONS
4.1 Dry Age-Related Macular Degeneration Market Size by Regions (2018-2023)
4.2 Americas Dry Age-Related Macular Degeneration Market Size Growth (2018-2023)
4.3 APAC Dry Age-Related Macular Degeneration Market Size Growth (2018-2023)
4.4 Europe Dry Age-Related Macular Degeneration Market Size Growth (2018-2023)
4.5 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Dry Age-Related Macular Degeneration Market Size by Country (2018-2023)
5.2 Americas Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
5.3 Americas Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dry Age-Related Macular Degeneration Market Size by Region (2018-2023)
6.2 APAC Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
6.3 APAC Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Dry Age-Related Macular Degeneration by Country (2018-2023)
7.2 Europe Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
7.3 Europe Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dry Age-Related Macular Degeneration by Region (2018-2023)
8.2 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
8.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRY AGE-RELATED MACULAR DEGENERATION MARKET FORECAST
10.1 Global Dry Age-Related Macular Degeneration Forecast by Regions (2024-2029)
10.1.1 Global Dry Age-Related Macular Degeneration Forecast by Regions (2024-2029)
10.1.2 Americas Dry Age-Related Macular Degeneration Forecast
10.1.3 APAC Dry Age-Related Macular Degeneration Forecast
10.1.4 Europe Dry Age-Related Macular Degeneration Forecast
10.1.5 Middle East & Africa Dry Age-Related Macular Degeneration Forecast
10.2 Americas Dry Age-Related Macular Degeneration Forecast by Country (2024-2029)
10.2.1 United States Dry Age-Related Macular Degeneration Market Forecast
10.2.2 Canada Dry Age-Related Macular Degeneration Market Forecast
10.2.3 Mexico Dry Age-Related Macular Degeneration Market Forecast
10.2.4 Brazil Dry Age-Related Macular Degeneration Market Forecast
10.3 APAC Dry Age-Related Macular Degeneration Forecast by Region (2024-2029)
10.3.1 China Dry Age-Related Macular Degeneration Market Forecast
10.3.2 Japan Dry Age-Related Macular Degeneration Market Forecast
10.3.3 Korea Dry Age-Related Macular Degeneration Market Forecast
10.3.4 Southeast Asia Dry Age-Related Macular Degeneration Market Forecast
10.3.5 India Dry Age-Related Macular Degeneration Market Forecast
10.3.6 Australia Dry Age-Related Macular Degeneration Market Forecast
10.4 Europe Dry Age-Related Macular Degeneration Forecast by Country (2024-2029)
10.4.1 Germany Dry Age-Related Macular Degeneration Market Forecast
10.4.2 France Dry Age-Related Macular Degeneration Market Forecast
10.4.3 UK Dry Age-Related Macular Degeneration Market Forecast
10.4.4 Italy Dry Age-Related Macular Degeneration Market Forecast
10.4.5 Russia Dry Age-Related Macular Degeneration Market Forecast
10.5 Middle East & Africa Dry Age-Related Macular Degeneration Forecast by Region (2024-2029)
10.5.1 Egypt Dry Age-Related Macular Degeneration Market Forecast
10.5.2 South Africa Dry Age-Related Macular Degeneration Market Forecast
10.5.3 Israel Dry Age-Related Macular Degeneration Market Forecast
10.5.4 Turkey Dry Age-Related Macular Degeneration Market Forecast
10.5.5 GCC Countries Dry Age-Related Macular Degeneration Market Forecast
10.6 Global Dry Age-Related Macular Degeneration Forecast by Type (2024-2029)
10.7 Global Dry Age-Related Macular Degeneration Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Santen Pharmaceuticals
11.1.1 Santen Pharmaceuticals Company Information
11.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
11.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Santen Pharmaceuticals Main Business Overview
11.1.5 Santen Pharmaceuticals Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Dry Age-Related Macular Degeneration Product Offered
11.2.3 Allergan Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Information
11.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Offered
11.3.3 Bausch Health Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bausch Health Main Business Overview
11.3.5 Bausch Health Latest Developments
11.4 Alimera Science
11.4.1 Alimera Science Company Information
11.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Offered
11.4.3 Alimera Science Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Alimera Science Main Business Overview
11.4.5 Alimera Science Latest Developments
11.5 Phio Pharmaceuticals
11.5.1 Phio Pharmaceuticals Company Information
11.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
11.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Phio Pharmaceuticals Main Business Overview
11.5.5 Phio Pharmaceuticals Latest Developments
11.6 Ocumension Therapeutics
11.6.1 Ocumension Therapeutics Company Information
11.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Offered
11.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Ocumension Therapeutics Main Business Overview
11.6.5 Ocumension Therapeutics Latest Developments
11.7 Belite Bio
11.7.1 Belite Bio Company Information
11.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Offered
11.7.3 Belite Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Belite Bio Main Business Overview
11.7.5 Belite Bio Latest Developments
11.8 Kubota Vision
11.8.1 Kubota Vision Company Information
11.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Offered
11.8.3 Kubota Vision Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Kubota Vision Main Business Overview
11.8.5 Kubota Vision Latest Developments
11.9 Iveric Bio
11.9.1 Iveric Bio Company Information
11.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Offered
11.9.3 Iveric Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Iveric Bio Main Business Overview
11.9.5 Iveric Bio Latest Developments
11.10 Eyestem Research
11.10.1 Eyestem Research Company Information
11.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Offered
11.10.3 Eyestem Research Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eyestem Research Main Business Overview
11.10.5 Eyestem Research Latest Developments
11.11 Y2 Solution
11.11.1 Y2 Solution Company Information
11.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Offered
11.11.3 Y2 Solution Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Y2 Solution Main Business Overview
11.11.5 Y2 Solution Latest Developments
11.12 Stealth Biotherapeutics
11.12.1 Stealth Biotherapeutics Company Information
11.12.2 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Offered
11.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Stealth Biotherapeutics Main Business Overview
11.12.5 Stealth Biotherapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dry Age-Related Macular Degeneration Market Size 2018-2029
2.1.2 Dry Age-Related Macular Degeneration Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Dry Age-Related Macular Degeneration Segment by Type
2.2.1 Oral
2.2.2 Injectables
2.3 Dry Age-Related Macular Degeneration Market Size by Type
2.3.1 Dry Age-Related Macular Degeneration Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
2.4 Dry Age-Related Macular Degeneration Segment by Application
2.4.1 Above 40 Years
2.4.2 Above 60 Years
2.4.3 Above 75 Years
2.5 Dry Age-Related Macular Degeneration Market Size by Application
2.5.1 Dry Age-Related Macular Degeneration Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
3 DRY AGE-RELATED MACULAR DEGENERATION MARKET SIZE BY PLAYER
3.1 Dry Age-Related Macular Degeneration Market Size Market Share by Players
3.1.1 Global Dry Age-Related Macular Degeneration Revenue by Players (2018-2023)
3.1.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Players (2018-2023)
3.2 Global Dry Age-Related Macular Degeneration Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 DRY AGE-RELATED MACULAR DEGENERATION BY REGIONS
4.1 Dry Age-Related Macular Degeneration Market Size by Regions (2018-2023)
4.2 Americas Dry Age-Related Macular Degeneration Market Size Growth (2018-2023)
4.3 APAC Dry Age-Related Macular Degeneration Market Size Growth (2018-2023)
4.4 Europe Dry Age-Related Macular Degeneration Market Size Growth (2018-2023)
4.5 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Dry Age-Related Macular Degeneration Market Size by Country (2018-2023)
5.2 Americas Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
5.3 Americas Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dry Age-Related Macular Degeneration Market Size by Region (2018-2023)
6.2 APAC Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
6.3 APAC Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Dry Age-Related Macular Degeneration by Country (2018-2023)
7.2 Europe Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
7.3 Europe Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dry Age-Related Macular Degeneration by Region (2018-2023)
8.2 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Type (2018-2023)
8.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL DRY AGE-RELATED MACULAR DEGENERATION MARKET FORECAST
10.1 Global Dry Age-Related Macular Degeneration Forecast by Regions (2024-2029)
10.1.1 Global Dry Age-Related Macular Degeneration Forecast by Regions (2024-2029)
10.1.2 Americas Dry Age-Related Macular Degeneration Forecast
10.1.3 APAC Dry Age-Related Macular Degeneration Forecast
10.1.4 Europe Dry Age-Related Macular Degeneration Forecast
10.1.5 Middle East & Africa Dry Age-Related Macular Degeneration Forecast
10.2 Americas Dry Age-Related Macular Degeneration Forecast by Country (2024-2029)
10.2.1 United States Dry Age-Related Macular Degeneration Market Forecast
10.2.2 Canada Dry Age-Related Macular Degeneration Market Forecast
10.2.3 Mexico Dry Age-Related Macular Degeneration Market Forecast
10.2.4 Brazil Dry Age-Related Macular Degeneration Market Forecast
10.3 APAC Dry Age-Related Macular Degeneration Forecast by Region (2024-2029)
10.3.1 China Dry Age-Related Macular Degeneration Market Forecast
10.3.2 Japan Dry Age-Related Macular Degeneration Market Forecast
10.3.3 Korea Dry Age-Related Macular Degeneration Market Forecast
10.3.4 Southeast Asia Dry Age-Related Macular Degeneration Market Forecast
10.3.5 India Dry Age-Related Macular Degeneration Market Forecast
10.3.6 Australia Dry Age-Related Macular Degeneration Market Forecast
10.4 Europe Dry Age-Related Macular Degeneration Forecast by Country (2024-2029)
10.4.1 Germany Dry Age-Related Macular Degeneration Market Forecast
10.4.2 France Dry Age-Related Macular Degeneration Market Forecast
10.4.3 UK Dry Age-Related Macular Degeneration Market Forecast
10.4.4 Italy Dry Age-Related Macular Degeneration Market Forecast
10.4.5 Russia Dry Age-Related Macular Degeneration Market Forecast
10.5 Middle East & Africa Dry Age-Related Macular Degeneration Forecast by Region (2024-2029)
10.5.1 Egypt Dry Age-Related Macular Degeneration Market Forecast
10.5.2 South Africa Dry Age-Related Macular Degeneration Market Forecast
10.5.3 Israel Dry Age-Related Macular Degeneration Market Forecast
10.5.4 Turkey Dry Age-Related Macular Degeneration Market Forecast
10.5.5 GCC Countries Dry Age-Related Macular Degeneration Market Forecast
10.6 Global Dry Age-Related Macular Degeneration Forecast by Type (2024-2029)
10.7 Global Dry Age-Related Macular Degeneration Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Santen Pharmaceuticals
11.1.1 Santen Pharmaceuticals Company Information
11.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
11.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Santen Pharmaceuticals Main Business Overview
11.1.5 Santen Pharmaceuticals Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Dry Age-Related Macular Degeneration Product Offered
11.2.3 Allergan Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Information
11.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Offered
11.3.3 Bausch Health Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Bausch Health Main Business Overview
11.3.5 Bausch Health Latest Developments
11.4 Alimera Science
11.4.1 Alimera Science Company Information
11.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Offered
11.4.3 Alimera Science Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Alimera Science Main Business Overview
11.4.5 Alimera Science Latest Developments
11.5 Phio Pharmaceuticals
11.5.1 Phio Pharmaceuticals Company Information
11.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
11.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Phio Pharmaceuticals Main Business Overview
11.5.5 Phio Pharmaceuticals Latest Developments
11.6 Ocumension Therapeutics
11.6.1 Ocumension Therapeutics Company Information
11.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Offered
11.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Ocumension Therapeutics Main Business Overview
11.6.5 Ocumension Therapeutics Latest Developments
11.7 Belite Bio
11.7.1 Belite Bio Company Information
11.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Offered
11.7.3 Belite Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Belite Bio Main Business Overview
11.7.5 Belite Bio Latest Developments
11.8 Kubota Vision
11.8.1 Kubota Vision Company Information
11.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Offered
11.8.3 Kubota Vision Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Kubota Vision Main Business Overview
11.8.5 Kubota Vision Latest Developments
11.9 Iveric Bio
11.9.1 Iveric Bio Company Information
11.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Offered
11.9.3 Iveric Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Iveric Bio Main Business Overview
11.9.5 Iveric Bio Latest Developments
11.10 Eyestem Research
11.10.1 Eyestem Research Company Information
11.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Offered
11.10.3 Eyestem Research Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eyestem Research Main Business Overview
11.10.5 Eyestem Research Latest Developments
11.11 Y2 Solution
11.11.1 Y2 Solution Company Information
11.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Offered
11.11.3 Y2 Solution Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Y2 Solution Main Business Overview
11.11.5 Y2 Solution Latest Developments
11.12 Stealth Biotherapeutics
11.12.1 Stealth Biotherapeutics Company Information
11.12.2 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Offered
11.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Stealth Biotherapeutics Main Business Overview
11.12.5 Stealth Biotherapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Dry Age-Related Macular Degeneration Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injectables
Table 4. Dry Age-Related Macular Degeneration Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 7. Dry Age-Related Macular Degeneration Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 10. Global Dry Age-Related Macular Degeneration Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Dry Age-Related Macular Degeneration Revenue Market Share by Player (2018-2023)
Table 12. Dry Age-Related Macular Degeneration Key Players Head office and Products Offered
Table 13. Dry Age-Related Macular Degeneration Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Dry Age-Related Macular Degeneration Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Dry Age-Related Macular Degeneration Market Size Market Share by Regions (2018-2023)
Table 18. Global Dry Age-Related Macular Degeneration Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Dry Age-Related Macular Degeneration Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Country (2018-2023)
Table 22. Americas Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 24. Americas Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 26. APAC Dry Age-Related Macular Degeneration Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Region (2018-2023)
Table 28. APAC Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 30. APAC Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 32. Europe Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Country (2018-2023)
Table 34. Europe Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 36. Europe Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Dry Age-Related Macular Degeneration
Table 45. Key Market Challenges & Risks of Dry Age-Related Macular Degeneration
Table 46. Key Industry Trends of Dry Age-Related Macular Degeneration
Table 47. Global Dry Age-Related Macular Degeneration Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Dry Age-Related Macular Degeneration Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Santen Pharmaceuticals Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 52. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
Table 53. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Santen Pharmaceuticals Main Business
Table 55. Santen Pharmaceuticals Latest Developments
Table 56. Allergan Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 57. Allergan Dry Age-Related Macular Degeneration Product Offered
Table 58. Allergan Main Business
Table 59. Allergan Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Allergan Latest Developments
Table 61. Bausch Health Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 62. Bausch Health Dry Age-Related Macular Degeneration Product Offered
Table 63. Bausch Health Main Business
Table 64. Bausch Health Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Bausch Health Latest Developments
Table 66. Alimera Science Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 67. Alimera Science Dry Age-Related Macular Degeneration Product Offered
Table 68. Alimera Science Main Business
Table 69. Alimera Science Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Alimera Science Latest Developments
Table 71. Phio Pharmaceuticals Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 72. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
Table 73. Phio Pharmaceuticals Main Business
Table 74. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Phio Pharmaceuticals Latest Developments
Table 76. Ocumension Therapeutics Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 77. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Offered
Table 78. Ocumension Therapeutics Main Business
Table 79. Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Ocumension Therapeutics Latest Developments
Table 81. Belite Bio Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 82. Belite Bio Dry Age-Related Macular Degeneration Product Offered
Table 83. Belite Bio Main Business
Table 84. Belite Bio Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Belite Bio Latest Developments
Table 86. Kubota Vision Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 87. Kubota Vision Dry Age-Related Macular Degeneration Product Offered
Table 88. Kubota Vision Main Business
Table 89. Kubota Vision Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Kubota Vision Latest Developments
Table 91. Iveric Bio Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 92. Iveric Bio Dry Age-Related Macular Degeneration Product Offered
Table 93. Iveric Bio Main Business
Table 94. Iveric Bio Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Iveric Bio Latest Developments
Table 96. Eyestem Research Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 97. Eyestem Research Dry Age-Related Macular Degeneration Product Offered
Table 98. Eyestem Research Main Business
Table 99. Eyestem Research Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Eyestem Research Latest Developments
Table 101. Y2 Solution Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 102. Y2 Solution Dry Age-Related Macular Degeneration Product Offered
Table 103. Y2 Solution Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Y2 Solution Main Business
Table 105. Y2 Solution Latest Developments
Table 106. Stealth Biotherapeutics Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 107. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Offered
Table 108. Stealth Biotherapeutics Main Business
Table 109. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Stealth Biotherapeutics Latest Developments
Table 1. Dry Age-Related Macular Degeneration Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injectables
Table 4. Dry Age-Related Macular Degeneration Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 7. Dry Age-Related Macular Degeneration Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 10. Global Dry Age-Related Macular Degeneration Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Dry Age-Related Macular Degeneration Revenue Market Share by Player (2018-2023)
Table 12. Dry Age-Related Macular Degeneration Key Players Head office and Products Offered
Table 13. Dry Age-Related Macular Degeneration Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Dry Age-Related Macular Degeneration Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Dry Age-Related Macular Degeneration Market Size Market Share by Regions (2018-2023)
Table 18. Global Dry Age-Related Macular Degeneration Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Dry Age-Related Macular Degeneration Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Country (2018-2023)
Table 22. Americas Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 24. Americas Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 26. APAC Dry Age-Related Macular Degeneration Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Region (2018-2023)
Table 28. APAC Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 30. APAC Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 32. Europe Dry Age-Related Macular Degeneration Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Country (2018-2023)
Table 34. Europe Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 36. Europe Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Dry Age-Related Macular Degeneration
Table 45. Key Market Challenges & Risks of Dry Age-Related Macular Degeneration
Table 46. Key Industry Trends of Dry Age-Related Macular Degeneration
Table 47. Global Dry Age-Related Macular Degeneration Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Dry Age-Related Macular Degeneration Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Santen Pharmaceuticals Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 52. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
Table 53. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Santen Pharmaceuticals Main Business
Table 55. Santen Pharmaceuticals Latest Developments
Table 56. Allergan Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 57. Allergan Dry Age-Related Macular Degeneration Product Offered
Table 58. Allergan Main Business
Table 59. Allergan Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Allergan Latest Developments
Table 61. Bausch Health Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 62. Bausch Health Dry Age-Related Macular Degeneration Product Offered
Table 63. Bausch Health Main Business
Table 64. Bausch Health Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Bausch Health Latest Developments
Table 66. Alimera Science Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 67. Alimera Science Dry Age-Related Macular Degeneration Product Offered
Table 68. Alimera Science Main Business
Table 69. Alimera Science Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Alimera Science Latest Developments
Table 71. Phio Pharmaceuticals Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 72. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Offered
Table 73. Phio Pharmaceuticals Main Business
Table 74. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Phio Pharmaceuticals Latest Developments
Table 76. Ocumension Therapeutics Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 77. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Offered
Table 78. Ocumension Therapeutics Main Business
Table 79. Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Ocumension Therapeutics Latest Developments
Table 81. Belite Bio Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 82. Belite Bio Dry Age-Related Macular Degeneration Product Offered
Table 83. Belite Bio Main Business
Table 84. Belite Bio Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Belite Bio Latest Developments
Table 86. Kubota Vision Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 87. Kubota Vision Dry Age-Related Macular Degeneration Product Offered
Table 88. Kubota Vision Main Business
Table 89. Kubota Vision Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Kubota Vision Latest Developments
Table 91. Iveric Bio Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 92. Iveric Bio Dry Age-Related Macular Degeneration Product Offered
Table 93. Iveric Bio Main Business
Table 94. Iveric Bio Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Iveric Bio Latest Developments
Table 96. Eyestem Research Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 97. Eyestem Research Dry Age-Related Macular Degeneration Product Offered
Table 98. Eyestem Research Main Business
Table 99. Eyestem Research Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Eyestem Research Latest Developments
Table 101. Y2 Solution Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 102. Y2 Solution Dry Age-Related Macular Degeneration Product Offered
Table 103. Y2 Solution Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Y2 Solution Main Business
Table 105. Y2 Solution Latest Developments
Table 106. Stealth Biotherapeutics Details, Company Type, Dry Age-Related Macular Degeneration Area Served and Its Competitors
Table 107. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Offered
Table 108. Stealth Biotherapeutics Main Business
Table 109. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Stealth Biotherapeutics Latest Developments
LIST OF FIGURES
Figure 1. Dry Age-Related Macular Degeneration Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dry Age-Related Macular Degeneration Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Dry Age-Related Macular Degeneration Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Dry Age-Related Macular Degeneration Sales Market Share by Country/Region (2022)
Figure 8. Dry Age-Related Macular Degeneration Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Dry Age-Related Macular Degeneration Market Size Market Share by Type in 2022
Figure 10. Dry Age-Related Macular Degeneration in Above 40 Years
Figure 11. Global Dry Age-Related Macular Degeneration Market: Above 40 Years (2018-2023) & ($ Millions)
Figure 12. Dry Age-Related Macular Degeneration in Above 60 Years
Figure 13. Global Dry Age-Related Macular Degeneration Market: Above 60 Years (2018-2023) & ($ Millions)
Figure 14. Dry Age-Related Macular Degeneration in Above 75 Years
Figure 15. Global Dry Age-Related Macular Degeneration Market: Above 75 Years (2018-2023) & ($ Millions)
Figure 16. Global Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2022
Figure 17. Global Dry Age-Related Macular Degeneration Revenue Market Share by Player in 2022
Figure 18. Global Dry Age-Related Macular Degeneration Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Dry Age-Related Macular Degeneration Market Size 2018-2023 ($ Millions)
Figure 20. APAC Dry Age-Related Macular Degeneration Market Size 2018-2023 ($ Millions)
Figure 21. Europe Dry Age-Related Macular Degeneration Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Dry Age-Related Macular Degeneration Market Size 2018-2023 ($ Millions)
Figure 23. Americas Dry Age-Related Macular Degeneration Value Market Share by Country in 2022
Figure 24. United States Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Region in 2022
Figure 29. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Type in 2022
Figure 30. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2022
Figure 31. China Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Country in 2022
Figure 38. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Figure 39. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Figure 40. Germany Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 54. APAC Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 55. Europe Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 57. United States Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 58. Canada Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 61. China Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 62. Japan Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 63. Korea Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 65. India Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 66. Australia Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 67. Germany Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 68. France Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 69. UK Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 70. Italy Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 71. Russia Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 72. Spain Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 75. Israel Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 78. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Dry Age-Related Macular Degeneration Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Dry Age-Related Macular Degeneration Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Dry Age-Related Macular Degeneration Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Dry Age-Related Macular Degeneration Sales Market Share by Country/Region (2022)
Figure 8. Dry Age-Related Macular Degeneration Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Dry Age-Related Macular Degeneration Market Size Market Share by Type in 2022
Figure 10. Dry Age-Related Macular Degeneration in Above 40 Years
Figure 11. Global Dry Age-Related Macular Degeneration Market: Above 40 Years (2018-2023) & ($ Millions)
Figure 12. Dry Age-Related Macular Degeneration in Above 60 Years
Figure 13. Global Dry Age-Related Macular Degeneration Market: Above 60 Years (2018-2023) & ($ Millions)
Figure 14. Dry Age-Related Macular Degeneration in Above 75 Years
Figure 15. Global Dry Age-Related Macular Degeneration Market: Above 75 Years (2018-2023) & ($ Millions)
Figure 16. Global Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2022
Figure 17. Global Dry Age-Related Macular Degeneration Revenue Market Share by Player in 2022
Figure 18. Global Dry Age-Related Macular Degeneration Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Dry Age-Related Macular Degeneration Market Size 2018-2023 ($ Millions)
Figure 20. APAC Dry Age-Related Macular Degeneration Market Size 2018-2023 ($ Millions)
Figure 21. Europe Dry Age-Related Macular Degeneration Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Dry Age-Related Macular Degeneration Market Size 2018-2023 ($ Millions)
Figure 23. Americas Dry Age-Related Macular Degeneration Value Market Share by Country in 2022
Figure 24. United States Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Region in 2022
Figure 29. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Type in 2022
Figure 30. APAC Dry Age-Related Macular Degeneration Market Size Market Share by Application in 2022
Figure 31. China Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Country in 2022
Figure 38. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Figure 39. Europe Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Figure 40. Germany Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Dry Age-Related Macular Degeneration Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Dry Age-Related Macular Degeneration Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 54. APAC Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 55. Europe Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 57. United States Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 58. Canada Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 61. China Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 62. Japan Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 63. Korea Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 65. India Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 66. Australia Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 67. Germany Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 68. France Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 69. UK Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 70. Italy Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 71. Russia Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 72. Spain Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 75. Israel Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Dry Age-Related Macular Degeneration Market Size 2024-2029 ($ Millions)
Figure 78. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Dry Age-Related Macular Degeneration Market Size Market Share Forecast by Application (2024-2029)
